VectivBio

Acquired

Ironwood Pharmaceuticals | Leaders in GI Health Innovation

Basel, Switzerland · Founded 2019 · $145.0M raised

Headquarters
Basel
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$145.0M
Last Round
$110.0M Venture RoundJan 2023
Rounds
3
Acquired by
Ironwood PharmaceuticalsMay 2023 · $1.0B

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

VectivBio was a clinical-stage biotechnology company headquartered in Basel, Switzerland, focused on the discovery and development of treatments for severe rare gastrointestinal diseases. Its lead candidate, apraglutide, is an investigational GLP-2 analog designed for short bowel syndrome with intestinal failure. VectivBio listed on NASDAQ in April 2021 and was acquired by Ironwood Pharmaceuticals in June 2023 for approximately $1 billion.

Summary

VectivBio is a Biotech company based in Basel, Switzerland, founded in 2019. It has raised $145.0M in total across 3 rounds, most recently a $110.0M Venture Round in Jan 2023. Investors include Ironwood Pharmaceuticals, CTI Life Sciences Fund and Novo Holdings A/S.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionMay 2023

Sign up to see all 4 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VectivBio on Indexed.vc
<a href="https://indexed.vc/companies/vectivbio"><img src="https://indexed.vc/api/badge/company/vectivbio" alt="VectivBio on Indexed.vc" width="260" height="76" /></a>